Co-Diagnostics, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Co-Diagnostics, Inc. payments for repurchase of common stock for the quarter ending 2023-12-31 was $159.67K, a 86.89% decline year-over-year.
- Co-Diagnostics, Inc. payments for repurchase of common stock for the quarter ending 2023-09-30 was $166.33K, a 98.40% decline year-over-year.
- Co-Diagnostics, Inc. payments for repurchase of common stock for the quarter ending 2023-06-30 was $555.73K.
- Co-Diagnostics, Inc. payments for repurchase of common stock for the quarter ending 2023-03-31 was $482.20K.
- Co-Diagnostics, Inc. payments for repurchase of common stock for fiscal 2023 was $1.36M, a 90.40% decline from fiscal 2022.
- Co-Diagnostics, Inc. payments for repurchase of common stock for fiscal 2022 was $14.21M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-12-31 | $159.67K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.36M 10-K · filed 2025-03-27 |
| 2023-09-30 | $166.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $555.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $12.65M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $482.20K 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $14.21M 10-K · filed 2024-03-14 |
| 2022-09-30 | $10.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |